Works matching DE "CHLAMYDIA infection vaccines"
Results: 16
Cost-effectiveness of Chlamydia Vaccination Programs for Young Women.
- Published in:
- Emerging Infectious Diseases, 2015, v. 21, n. 6, p. 960, doi. 10.3201/eid2106.141270
- By:
- Publication type:
- Article
Impact of the Levonorgestrel-Releasing Intrauterine System on the Progression of Chlamydia trachomatis Infection to Pelvic Inflammatory Disease in a Baboon Model.
- Published in:
- Journal of Infectious Diseases, 2018, v. 217, n. 4, p. 656, doi. 10.1093/infdis/jix545
- By:
- Publication type:
- Article
Identification of Chlamydia trachomatis Antigens Recognized by T Cells From Highly Exposed Women Who Limit or Resist Genital Tract Infection.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Immunity against a Chlamydia infection and disease may be determined by a balance of IL-17 signaling.
- Published in:
- Immunology & Cell Biology, 2014, v. 92, n. 3, p. 287, doi. 10.1038/icb.2013.92
- By:
- Publication type:
- Article
Antibody and Cytokine Responses of Koalas (Phascolarctos cinereus) Vaccinated with Recombinant Chlamydial Major Outer Membrane Protein (MOMP) with Two Different Adjuvants.
- Published in:
- PLoS ONE, 2016, v. 11, n. 5, p. 1, doi. 10.1371/journal.pone.0156094
- By:
- Publication type:
- Article
A Prototype Recombinant-Protein Based Chlamydia pecorum Vaccine Results in Reduced Chlamydial Burden and Less Clinical Disease in Free-Ranging Koalas (Phascolarctos cinereus).
- Published in:
- PLoS ONE, 2016, v. 11, n. 1, p. 1, doi. 10.1371/journal.pone.0146934
- By:
- Publication type:
- Article
Simultanceous Subcutaneous and Intranasal Admimistration of a CAF01-Adjuvanted Chlamydia Vaccine Elicits Elevated IgA and Protective TH1/Th17 Responses in the Genital Tract.
- Published in:
- Frontiers in Immunology, 2017, p. 1, doi. 10.3389/fimmu.2017.00569
- By:
- Publication type:
- Article
VACCINE PROTECTS AGAINST CHLAMYDIA.
- Published in:
- AIDS Patient Care & STDs, 1999, v. 13, n. 7, p. 441
- Publication type:
- Article
Structural and Immunological Characterization of Novel Recombinant MOMP-Based Chlamydial Antigens.
- Published in:
- Vaccines, 2018, v. 6, n. 1, p. 2, doi. 10.3390/vaccines6010002
- By:
- Publication type:
- Article
A Protective Vaccine against Chlamydia Genital Infection Using Vault Nanoparticles without an Added Adjuvant.
- Published in:
- Vaccines, 2017, v. 5, n. 1, p. 3, doi. 10.3390/vaccines5010003
- By:
- Publication type:
- Article
Chlamydia Vaccines: Strategies and Status.
- Published in:
- BioDrugs, 2002, v. 16, n. 1, p. 19, doi. 10.2165/00063030-200216010-00003
- By:
- Publication type:
- Article
New way to Identify and Block -- Traits in Harmful Pathogens.
- Published in:
- Current Trends in Biotechnology & Pharmacy, 2012, v. 6, n. 1, p. 118
- By:
- Publication type:
- Article
A Probiotic Adjuvant Lactobacillus rhamnosus Enhances Specific Immune Responses after Ocular Mucosal Immunization with Chlamydial Polymorphic Membrane Protein C.
- Published in:
- PLoS ONE, 2016, v. 11, n. 9, p. 1, doi. 10.1371/journal.pone.0157875
- By:
- Publication type:
- Article
Live-attenuated influenza viruses as delivery vectors for Chlamydia vaccines.
- Published in:
- Immunology, 2007, v. 122, n. 1, p. 28, doi. 10.1111/j.1365-2567.2007.02608.x
- By:
- Publication type:
- Article
The Potential for Vaccine Development against Chlamydial Infection and Disease.
- Published in:
- Journal of Infectious Diseases, 2000, v. 181, p. S538, doi. 10.1086/315630
- By:
- Publication type:
- Article
Therapeutic effect of a Chlamydia pecorum recombinant major outer membrane protein vaccine on ocular disease in koalas (Phascolarctos cinereus).
- Published in:
- PLoS ONE, 2019, v. 14, n. 01, p. 1, doi. 10.1371/journal.pone.0210245
- By:
- Publication type:
- Article